Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Current concepts of radiation treatment of carcinoma in situ of the testis

  • 22 Accesses

  • 19 Citations

Summary

During a recent international workshop on carcinoma in situ and cancer of the testis held in November 1992, there was consensus about the management of the contralateral testis in patients with unilateral testicular cancer [20]. Such men should be offered a biopsy of the contralateral testis. This consensus was based on (1) the high prevalence of carcinoma in situ (CIS) in the contralateral testis found not only in Danish men but also in studies from other countries and (2) the possibility of eradicating the CIS and thereby preventing the development of invasive cancer by means of localized irradiation with preservation of testosterone production in the testis. The aim of this paper is to outline the present status of the radiation treatment of CIS of the testis.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Berthelsen JG, Skakkebæk NE (1981) Value of testicular biopsy in diagnosing carcinoma in situ testis. Scand J Urol Nephrol 15:165–168

  2. 2.

    Berthelsen JG, Skakkebæk NE, Maase H von der, Sørensen BL, Mogensen P (1982) Screening for carcinoma in situ of the contralateral testis in patients with germinal testicular cancer. BMJ 285:1683–1686

  3. 3.

    Berthelsen JG, Engelholm SA, Maase H von der, Rørth M (1983) Serum testosterone, LH, and FSH in patients with testicular cancer before and after radio- and chemotherapy. Scand J Urol 17:287–290

  4. 4.

    Bottomley D, Fisher C, Hendry WF, Horwich A (1990) Persistent carcinoma in situ of the testis after chemotherapy for advanced testicular germ cell tumours. Br J Urol 66:420–424

  5. 5.

    Bruun E, Frimodt-Møller C, Giwercman A, Lenz S, Skakkebæk NE (1987) Testicular biopsy as an outpatient procedure in screening for carcinoma-in-situ: complications and the patient's acceptance. Int J Androl 10:199–202

  6. 6.

    Daugaard G, Rørth M, Maase H von der, Skakkebæk NE (1992) Management of extragonadal germ-cell tumors and the significance of bilateral testicular biopsies. Ann Ocol 3:283–289

  7. 7.

    Dieckmann K-P, Loy V (1993) Prevalence of bilateral testicular germ cell tumors and early detection by testicular intraepithelial neoplasia. Eur Urol 23 [Suppl 2]:22–23

  8. 8.

    Dieckmann K-P, Besserer A, Loy V (1993) Low-dose radiation therapy for testicular intraepithelial neoplasia. J Cancer Res Clin Oncol 119:355–359

  9. 9.

    Dieckmann K-P, Kaup F, Loy V (1993) False-negative biopsy for testicular intraepithelial neoplasia. J Cancer Res Clin Oncol 119:1–4

  10. 10.

    Fordham MVP, Mason MD, Blackmore C, Hendry WF, Horwich A (1990) Management of the contralateral testis in patients with testicular germ cell cancer. Br J Urol 65:290–293

  11. 11.

    Fosså SD, Aass N (1989) Cisplatin-based chemotherapy does not eliminate the risk of a second testicular cancer. Br J Urol 63:531–534

  12. 12.

    Giwercman A (1992) Carcinoma-in-situ of the testis: screening and management. Scand J Urol Nephrol 148 [Suppl]: 1–47

  13. 13.

    Giwercman A, Berthelsen JG, Müller J, Maase H von der, Skakkebæk NE (1987) Screening for carcinoma-in-situ of the testis. Int J Androl 10:173–180

  14. 14.

    Giwercman A, Bruun E, Frimodt-Møller C, Skakkebæk NE (1989) Prevalence of carcinoma in situ and other histopathological abnormalities in testes of men with a history of cryptorchidism. J Urol 142:998–1002

  15. 15.

    Giwercman A, Cantell L, Marks A (1991) Placental-like alkaline phosphatase as a marker of carcinoma-in-situ of the testis. Comparison with monoclonal antibodies M2A and 43–9f. APMIS 99:586–594

  16. 16.

    Giwercman A, Müller J, Skakkebæk NE (1991) Prevalence of carcinoma-in-situ and other histopathological abnormalities in testes from 399 men who died suddenly and unexpectedly. J Urol 145:77–80

  17. 17.

    Giwercman A, Maase H von der, Berthelsen JG, Rørth M, Bertelsen A, Skakkebæk NE (1991) Localized irradiation of testes with carcinoma in situ: effects on Leydig cell function and eradication of malignant germ cells in 20 patients. J Clin Endocrinol Metab 73:596–603

  18. 18.

    Giwercman A, Andrews PW, Jørgensen N, Müller J, Græm N, Skakkebæk NE (1993) Immunohistochemical expression of embryonal marker TRA-1–60 in carcinoma in situ and germ cell tumors of the testis. Cancer 72:1308–1314

  19. 19.

    Giwercman A, Maase H von der, Rørth M, Skakkebæk NE (1993) Semen quality in testicular tumour and CIS in the contralateral testis. Lancet 341:384–385

  20. 20.

    Grigor KM, Rorth M (1993) Should the contralateral testis be biopsied? Round table discussion. Eur Urol 23:129–135

  21. 21.

    Hakulinen T, Andersen AA, Malker B, Pukkala E, Schou G, Tulinius H (1986) Trends in cancer incidence in the Nordic countries. APMIS [Suppl] 288

  22. 22.

    Harland SJ, Cook PA, Fosså SD et al. (1993) Risk factor for carcinoma in situ of the contralateral testis in patients with testicular cancer. Eur Urol 23:115–119

  23. 23.

    Holstein AF, Schütte B, Becker H, Hartmann M (1987) Morphology of normal and malignant germ cells. Int J Androl 10:1–18

  24. 24.

    Leiper AD, Grant DB, Chessells JM (1983) The effect of testicular irradiation on Leydig cell function in prepubertal boys with acute lymphoblastic leukaemia. Arch Dis Child 58:906–910

  25. 25.

    Lenz S, Giwercman A, Skakkebæk NE, Bruun E, Frimodt-Møller C (1987) Ultrasound in detection of early neoplasia of the testis. Int J Androl 10:187–190

  26. 26.

    Loy V, Dieckmann K-P (1993) Prevalence of contralateral testicular intraepithelial neoplasia (carcinoma in situ) in patients with testicular germ cell tumour. Eur Urol 23:120–122

  27. 27.

    Maase H von der, Berthelsen JG, Jacobsen GK, et al. (1985) Carcinoma-in-situ of testis eradicated by chemotherapy. Lancet I:98

  28. 28.

    Maase H von der, Giwercman A, Skakkebæk NE (1986) Radiation treatment of carcinoma-in-situ of testis. Lancet I:624–625

  29. 29.

    Maase H von der, Rørth M, Walbom-Jørgensen S, et al (1986) Carcinoma in situ of contralateral testis in patients with testicular germ cell cancer: study of 27 cases in 500 patients. BMJ 293:1398–1401

  30. 30.

    Maase H von der, Meinecke B, Skakkebæk NE (1988) Residual carcinoma-in-situ of contralateral testis after chemotherapy. Lancet I:477–478

  31. 31.

    Montie JE (1993) Carcinoma in situ of the testis and bilateral carcinoma. Urol Clin North Am 20:127–132

  32. 32.

    Müller J, Skakkebæk NE (1981) Microspectrophotometric DNA measurements of carcinoma-in-situ germ cells in the testis. Int J Androl [Suppl] 4:211–221

  33. 33.

    Müller J, Skakkebæk NE (1984) Testicular carcinoma in situ in children with androgen insensitivity (testicular feminisation) syndrome. BMJ 288:1419–1420

  34. 34.

    Müller J, Skakkebæk NE, Ritzén EM, Plöen L, Petersen KE (1985) Carcinoma in situ of the testis in children with 45,X/46,XY gonadal dysgenesis. J Pediatr 106:431–436

  35. 35.

    Mumperow E, Lauke H, Holstein AF, Hartmann M (1992) Further practical experiences in the recognition and management of carcinoma in situ of the testis. Urol Int 48:162–166

  36. 36.

    Nistal N, Codesal J, Paniagua R (1989) Carcinoma in situ of the testis in infertile men. A histological, immunocytochemical, and cytophotometric study of DNA content. J Pathol 159:205–210

  37. 37.

    Nüesch-Bachmann IH, Hedinger C (1977) Atypische Spermatogonien als Präkanzerose. Schweiz Med Wochenschr 107:795–801

  38. 38.

    Østerlind A, Berthelsen JG, Abildgaard N, et al (1991) Risk of bilateral testicular germ cancer in Denmark: 1960–1984. J Natl Cancer Inst 83:1391–1395

  39. 39.

    Prener A, Østerlind A (1985) Danish Cancer Registry, Copenhagen, p 44

  40. 40.

    Pryor JP, Cameron KM, Chilton CP, et al (1983) Carcinoma in situ in testicular biopsies from men presenting with infertility. Br J Urol 55:780–784

  41. 41.

    Rowley MJ, Leach DR, Warner GA, Heller CG (1974) Effect of graded doses of ionizing radiation on the human testis. Radiat Res 59:665–678

  42. 42.

    Schütte B (1988) Early testicular cancer in severe oligozoospermia. In: Holstein AF, Leidenberger F, Hölzer KH, Bettendorf G (eds) Carl Schirren Symposium: advances in andrology. Diesbach, Berlin, pp 188–190

  43. 43.

    Shalet SM, Tsatsoulis A, Whitehead E, Read G (1989) Vulnerability of the human Leydig cell to radiation damage is dependent upon age. J Endocrinol 120:161–165

  44. 44.

    Skakkebæk NE (1972) Possible carcinoma-in-situ of the testis. Lancet II:516–517

  45. 45.

    Skakkebæk NE (1978) Carcinoma in situ of the testis: frequency and relationship to invasive germ cell tumours in infertile men. Histopathology 2:157–170

  46. 46.

    Skakkebæk NE, Berthelsen JG, Müller J (1982) Carcinoma-in-situ of the undescended testis. Urol Clin North Am 9:377–385

  47. 47.

    Skakkebæk NE, Berthelsen JG, Giwercman A, Mülleer J (1987) Carcinoma-in-situ of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 10:19–28

  48. 48.

    Thompson J, Williams CJ, Whitehouse JMA, Mead GM (1988) Bilateral testicular germ cell tumours: an increasing incidence and prevention by chemotherapy. Br J Urol 62:374–376

  49. 49.

    Visfeldt J, Giwercman A, Skakkebæk NE (1992) Monoclonal antibody 43–9F: an immunohistochemical marker of embryonal carcinoma of the testis. APMIS 100:63–70

Download references

Author information

Correspondence to A. Giwercman.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Giwercman, A., von der Maase, H., Rørth, M. et al. Current concepts of radiation treatment of carcinoma in situ of the testis. World J Urol 12, 125–130 (1994). https://doi.org/10.1007/BF00192268

Download citation

Keywords

  • Public Health
  • Carcinoma
  • Testosterone
  • Present Status
  • International Workshop